Bacterial and fungal cell membranes and macromolecules

Bacterial and fungal cell membranes and macromolecules encompass a diverse array of essential structures and biosynthetic processes required for microbial life. The cell membrane acts as a selective barrier and a site for critical enzymatic activities, such as oxidative phosphorylation and nutrient transport (StatPearls: NBK553016). Macromolecules, including DNA, RNA, and proteins, serve as the blueprint and machinery for cellular replication and maintenance (PubMed: 24432110). In clinical practice, these components are the primary targets for most antimicrobial therapies. For instance, polymyxins and daptomycin target bacterial membranes to cause lethal leakage or depolarization, while polyenes like amphotericin B bind to ergosterol in fungal membranes to create pores (PubMed: 27307115, StatPearls: NBK526102). Other drugs, such as fluoroquinolones and aminoglycosides, target the macromolecules themselves or the enzymes responsible for their synthesis, effectively halting microbial growth or inducing cell death (PubMed: 12654757). Because these targets are often distinct from human cellular components, they provide a basis for selective toxicity, although the emergence of resistance remains a significant therapeutic challenge.

Other names

Microbial cell envelopeMicrobial membranesBacterial cell wall and membraneFungal cell wall and membraneMicrobial macromolecules

Antimicrobial agents target these structures through various mechanisms: disrupting membrane integrity and permeability (e.g., polyenes, lipopeptides), inhibiting cell wall biosynthesis (e.g., beta-lactams, echinocandins), interfering with nucleic acid synthesis and replication (e.g., quinolones, rifamycins), or blocking protein synthesis by binding to ribosomal subunits (e.g., aminoglycosides, tetracyclines).